E84.9
Cystic fibrosis, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Cystic fibrosis (CF) is a hereditary disorder that primarily affects the lungs and digestive system. It causes thick and sticky mucus to build up in these organs, leading to breathing problems, infections, and nutritional challenges. While CF can impact various parts of the body, its most significant effects are seen in the respiratory and gastrointestinal systems. The condition is lifelong and requires ongoing management to improve quality of life and health outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations: Cystic fibrosis is caused by mutations in the CFTR gene, which encodes a protein responsible for regulating salt and water movement in and out of cells. Inheritance pattern: The disorder is inherited in an autosomal recessive manner, meaning a person needs to inherit two defective copies of the CFTR gene—one from each parent—to develop the disease. No environmental causes: CF is not caused by environmental factors or lifestyle choices. Family history: Having a family history of CF increases the likelihood of inheriting the condition.
Key Symptoms: Persistent cough that produces mucus Frequent lung infections, including pneumonia and bronchitis Wheezing or shortness of breath Frequent, greasy, bulky stools or difficulty maintaining weight despite a good appetite Salty-tasting skin or sweat Poor growth and delayed development in children Nasal polyps or persistent sinus infections Clogged or thickened mucus in ducts of the pancreas, leading to digestive problems
Diagnostic & Treatment
Diagnosis Path: Newborn screening: A heel prick blood test that checks for elevated levels of immunoreactive trypsinogen (IRT), an early screening marker for CF. Sweat chloride test: The most common confirmatory test, which measures the amount of salt in sweat; high levels are indicative of CF. Genetic testing: Analysis of the CFTR gene to identify specific mutations. Additional assessments: Chest X-rays, lung function tests, and stool analysis to evaluate the extent of organ involvement and complications.
Treatment Protocols: Airway clearance techniques: Physiotherapy and devices to help loosen and remove thick mucus from the lungs. Medications: Antibiotics for infections, mucus-thinning agents, bronchodilators to open airways, and CFTR modulators to improve protein function in some cases. Nutritional support: High-calorie, high-fat diets, pancreatic enzymes to aid digestion, and vitamin supplements. Regular monitoring: Routine check-ups with healthcare providers to track lung function and growth, and to adjust treatments as needed. Lung transplantation: In advanced cases, lung transplants may be considered. Multidisciplinary care: A team approach, including pulmonologists, nutritionists, and other specialists, to address various aspects of the disease.
Clinical Advice & FAQs
Billing Guidance
Is E84.9 a billable ICD-10 code?
Yes, E84.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E84.9?
Clinical documentation must specify the nature of Cystic fibrosis, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference